Medicinal cannabis was legalised in Germany in March 2017, and many European are following suit. Investing in medicinal cannabis offers opportunities for first movers, but also challenges. What awaits investors in the coming years? What are the opportunities and challenges?
To answer these questions, Andrew de Roy is joined by Marguerite Arnold, the founder of MedPayRx and a cannabis industry journalist, consultant and patient advocate.